| Literature DB >> 16298551 |
Gregory J Brunn1, Jeffrey L Platt.
Abstract
The sepsis syndrome is thought to occur when microbial products activate Toll-like receptors stimulating widespread inflammation, in turn causing organ failure, shock and death. However, recent discoveries reveal that: (i) not only microbial substances but also endogenous molecules can trigger Toll-like receptors; (ii) Toll-like receptor-4, the endotoxin receptor, is constitutively suppressed; and (iii) the first step in sepsis could be the release of Toll-like receptor-4 from suppression. These discoveries suggest that endotoxin might not always initiate the sepsis syndrome and they explain why anti-endotoxin therapies fail. The discoveries also suggest new therapeutic targets - endogenous agonists and Toll-like receptor regulators - for treatment of sepsis.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16298551 DOI: 10.1016/j.molmed.2005.11.002
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951